High EGFR copy number predicts benefits from tyrosine kinase inhibitor treatment for non-small cell lung cancer patients with wild-type EGFR.

J Transl Med · 2013 · PMC3635875 · PMID 23557218

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

marginally significantno p-value reported

2.1 months, p = 0.201), despite a marginally significant difference due to the sample size.

also in 26,082 other papers

showed a trendno p-value reported

A high EGFR copy number showed a trend toward poor prognosis in the absence of EGFR-TKI treatment [ 10 , 11 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.